Eli Lilly welcomes you to a focused clinical webinar exploring the importance of acting early and comprehensively in the management of type 2 diabetes. This discussion will examine the clinical consequences of therapeutic inertia and the importance of initiating effective interventions before irreversible metabolic and vascular damage occurs. The webinar will also review the rationale for adopting a holistic, multifactorial approach to type 2 diabetes care that extends beyond glycemic control alone.
Through an evidence-based overview, the session will explore the importance of integrating weight management, cardiovascular risk reduction, and cardiorenal protection alongside individualized glycemic targets to address the complex and progressive nature of the disease. In addition, the discussion will highlight practical strategies for implementing early, proactive, and treat-to-target…
